Exact Sciences Completes 40,000 Cologuard Tests during First Quarter 2016
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street lower on AI spending jitters; oil prices rebound
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
Exact Sciences (EXAS) Tops Q1 EPS by 3c
May 3, 2016 7:32 AM EDTExact Sciences (NASDAQ: EXAS) reported Q1 EPS of ($0.49), $0.03 better than the analyst estimate of ($0.52). Revenue for the quarter came in at $14.8 million versus the consensus estimate of $14.83 million.
For earnings history and earnings-related data on Exact Sciences (EXAS) click here.
... More


